Caprospinol, Therapy for Alzheimer's Disease (AD)

 
Key Data:
Drug (brand/generic)
Caprospinol (SP-233)
Company/licensee
Samaritan Pharmaceuticals
Therapy class
Spirostenol
Product description
Anti-amyloid agent
Current indication
Alzheimer's disease
Market sector
CNS
Development status
Phase I

Return to Project



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development